Publications
51
Citations
682
Est. group size
~26
Recurring co-author estimate
Active years
16
Publishing since 2011
Typically publishes in teams of ~6 · 20% small-team papers (≤3 authors) · across 13 venues
- Features of early and late recurrence versus de novo metastatic ccRCC: Findings from JAVELIN Renal 101.
Journal of Clinical Oncology · 2026
- Study of JAK inhibition in stem-like prostate cancer (JASPER): A phase 1/2 multicenter study of ruxolitinib and enzalutamide in castration resistant prostate cancer undergoing lineage plasticity.
Journal of Clinical Oncology · 2025
- Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era
Cancer Immunology Immunotherapy · 2024
- Enhancing Veteran Engagement, Demonstrating Value and Supporting Oncology Team Wellness: One Service Delivery Model of Integrating Health Psychology Services in VA Oncology Care
Archives of Clinical and Biomedical Research · 2024
- Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma
Frontiers in Oncology · 2022
- Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma
Cancers · 2022
- Targeting resistant prostate cancer, with or without DNA repair defects, using the combination of ceralasertib (ATR inhibitor) and olaparib (the TRAP trial).
Journal of Clinical Oncology · 2022
- Increased incidence of immune-mediated myocarditis in advanced skin malignancies treated with immune checkpoint inhibitors in the COVID-19 era.
Journal of Clinical Oncology · 2022
- Focal radiation with pulsed systemic therapy of abiraterone, androgen deprivation therapy (ADT), olaparib towards castration-sensitive oligometastatic prostate cancer (FAALCON Trial).
Journal of Clinical Oncology · 2022
- Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer
Lung Cancer · 2021
- Implementation of a Multidisciplinary Care Pathway via an Emergency Department-ICU to Improve Care of Emergency Department Patients Presenting With Leukostasis
Critical Care Explorations · 2020
- Toxicities with combination BRAF and MEK inhibition in resected stage III melanoma.
Journal of Clinical Oncology · 2020
- Immunotherapy for mucosal melanoma
Annals of Translational Medicine · 2019
- Focal radiation for oligometastatic castration-resistant prostate cancer (FORCE): A phase II randomized trial.
Journal of Clinical Oncology · 2019
- Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy
BioDrugs · 2018
- Journal of Clinical Oncology×13
- Frontiers in Oncology×2
- Annals of Oncology×2
- Circulation×2
- Clinical Diabetes and Endocrinology×1
- Charles B. Nguyen
Medicine · University of Michigan
- Yuanquan Yang
Medicine · The Ohio State University
- Chamila Perera
Medicine · University of Michigan
- Daniel H. Hovelson
Medicine · University of Michigan
- Lingbin Meng
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile